(Q34108608)

31 July 2017

1 reference

title

Buprenorphine and naloxone for heroin dependence (English)

1 reference

31 July 2017

1 reference

Johnson RE

1

1 reference

31 July 2017

McCagh JC

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Current Psychiatry Reports

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

519-526

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-000-0012-8

31 July 2017

exact match

0 references

cites work

Comparison of buprenorphine and methadone in the treatment of opioid dependence

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0012-8

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0012-8

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0012-8

Methadone-naloxone mixtures for use in methadone maintenance programs. I. An evaluation in man of their pharmacological feasibility. II. Demonstration of acute physical dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-000-0012-8

A combination of buprenorphine and naloxone compared with buprenorphine administered intramuscularly in postoperative patients

21 January 2018

1 reference

12 December 2020

A controlled trial of buprenorphine treatment for opioid dependence

1 reference

12 December 2020

Acute administration of buprenorphine in humans: partial agonist and blockade effects

1 reference

12 December 2020

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

1 reference

12 December 2020

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

1 reference

12 December 2020

Sublingual versus subcutaneous buprenorphine in opiate abusers.

1 reference

12 December 2020

Clinical pharmacology of narcotic antagonists

1 reference

12 December 2020

Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet

1 reference

12 December 2020

Buprenorphine and naloxone interactions in methadone maintenance patients

1 reference

12 December 2020

Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing.

1 reference

12 December 2020

Analysis of epidemiological data on agonist-antagonist analgesics

1 reference

12 December 2020

Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans

1 reference

12 December 2020

Cases of buprenorphine abuse in India

1 reference

12 December 2020

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

1 reference

12 December 2020

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

1 reference

12 December 2020

Emergence of buprenorphine dependence

1 reference

12 December 2020

Sublingual absorption of selected opioid analgesics

1 reference

12 December 2020

A pilot study of primary-care-based buprenorphine maintenance for heroin dependence

1 reference

12 December 2020

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

1 reference

12 December 2020

Subjective and physiologic effects of intravenous buprenorphine in humans.

1 reference

12 December 2020

The use of buprenorphine and temazepam by drug injectors

1 reference

12 December 2020

Bioavailability of sublingual buprenorphine

1 reference

12 December 2020

Decline in abuse of pentazocine/tripelennamine (T's and Blues) associated with the addition of naloxone to pentazocine tablets

1 reference

12 December 2020

Buprenorphine versus methadone maintenance for opioid dependence

1 reference

12 December 2020

The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand

1 reference

12 December 2020

Comparison of intramuscular buprenorphine and a buprenorphine/naloxone combination in the treatment of post-operative pain

1 reference

12 December 2020

Clinical pharmacology of buprenorphine: ceiling effects at high doses

1 reference

12 December 2020

A controlled trial of daily versus thrice-weekly buprenorphine administration for the treatment of opioid dependence.

1 reference

12 December 2020

1 reference

12 December 2020

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

1 reference

12 December 2020

Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet

1 reference

12 December 2020

The impact of the addition of naloxone on the use and abuse of pentazocine

1 reference

12 December 2020

Buprenorphine alone and in combination with naloxone in non-dependent humans.

1 reference

12 December 2020

Abuse of buprenorphine

1 reference

12 December 2020

Buprenorphine abuse among opiate addicts

1 reference

12 December 2020

Combined naloxone/methadone preparations for opiate substitution therapy

1 reference

12 December 2020

Buprenorphine and naloxone alone and in combination in opioid-dependent humans

1 reference

12 December 2020

Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations

1 reference

12 December 2020

Effects of sublingually given naloxone in opioid-dependent human volunteers

1 reference

12 December 2020

Naloxone-induced withdrawal in patients with buprenorphine dependence.

1 reference

12 December 2020

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers

1 reference

12 December 2020

Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients

1 reference

12 December 2020

10.1007/S11920-000-0012-8

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1041176611

0 references

1 reference